|Weiss: Protection by Neutralizing Antibodies
|Combo: DNA, protein & VLP vaccines
|Study Start Date:
|Study Made Public:
The induction of neutralising antibodies to HIV env proteins by modifications to gp41.
CAVD 314 is a preclinical rabbit study investigating several prime-boost regimens in which HIV env gp160 protein and modified gp41 constructs were boosted with virus-like particles containing the corresponding modified gp41 proteins.
Sign in to see full information about this study and to download study data.